| treatment of chronic hepatitis c virus in the virginia department of corrections: can compliance overcome racial differences to response? | chronic hepatitis c virus (hcv) is common in the correctional setting and there are few data on the use of interferon (ifn)/ribavirin(rvn) combination therapy in this population. given the high proportion of african americans (aa) in correctional facilities, which may be associated with reduced response rates, the correctional setting allows a unique opportunity to compare the response rates of aa to caucasians (ca). the present study describes our experience of treating hcv in the inmate popula ... | 2004 | 15128352 |
| the spectrum of chronic hepatitis c virus infection in the virginia correctional system: development of a strategy for the evaluation and treatment of inmates with hcv. | chronic hepatitis c virus (hcv) is common in the inmate population of the united states. long-standing hcv can progress to cirrhosis, which can contribute to significant morbidity and mortality. however, those inmates with histologically mild disease are unlikely to develop liver-related morbidity or mortality during their period of incarceration. our objective was to develop an economic strategy for evaluation and treatment of inmates with chronic hcv. | 2005 | 15667488 |
| increases in acute hepatitis b virus infections - kentucky, tennessee, and west virginia, 2006-2013. | as many as 2.2 million persons in the united states are chronically infected with hepatitis b virus (hbv) (1), and approximately 15%-25% of persons with chronic hbv infection will die prematurely from cirrhosis or liver cancer (2). since 2006, the overall u.s. incidence of acute hbv infection has remained stable; the rate in 2013 was 1.0 case per 100,000 persons (3). hepatitis b vaccination is highly effective in preventing hbv infection and is recommended for all infants (beginning at birth), a ... | 2016 | 26821369 |
| increases in hepatitis c virus infection related to injection drug use among persons aged ≤30 years - kentucky, tennessee, virginia, and west virginia, 2006-2012. | hepatitis c virus (hcv) infection is the most common blood-borne infection in the united states, with approximately three million persons living with current infection. percutaneous exposure to contaminated blood is the most efficient mode of transmission, and in the united states, injection drug use (idu) is the primary risk factor for infection. state surveillance reports from the period 2006-2012 reveal a nationwide increase in reported cases of acute hcv infection, with the largest increases ... | 2015 | 25950251 |
| hepatitis c virus infection among women giving birth - tennessee and united states, 2009-2014. | hepatitis c virus (hcv) affects an estimated 3.5 million persons in the united states (1), making it the most common bloodborne infection in the country. recent surveillance data showed increased rates of hcv infection among adolescents and adults who are predominantly white, live in nonurban areas, and have a history of injection drug use.* u.s. birth certificate data were used to analyze trends and geographic variations in rates of hcv infection among women giving birth during 2009-2014. birth ... | 2017 | 28493860 |
| distinctive gene expression profiles characterize donor biopsies from hcv-positive kidney donors. | because of the shortage of organs for transplantation, procurement of kidneys from extended criteria donors is inevitable. frequently, donors infected with hepatitis c virus (hcv) are used. to elucidate an initial compromise of molecular pathways in hcv graft, gene expression profiles were evaluated. | 2010 | 20935597 |
| vietnamese community screening for hepatitis b virus and hepatitis c virus. | asian americans represent an important cohort at high risk for viral hepatitis. to determine the prevalence of hepatitis b virus (hbv) and hepatitis c virus (hcv) infection and hbv vaccination in a vietnamese community, a total of 322 vietnamese subjects from a local doctor's office and annual vietnamese health fair were included in this study. demographic and clinical data were collected. 2.2% of the screened cohort tested positive for anti-hcv and 9.3% tested positive for hbsag. unlike hbv-pos ... | 2011 | 20196807 |
| hepatitis c virus transmission in hemodialysis units: importance of infection control practices and aseptic technique. | we investigated 4 hepatitis c virus (hcv) infection outbreaks at hemodialysis units to identify practices associated with transmission. apparent failures to follow recommended infection control precautions resulted in patient-to-patient hcv transmission, through cross-contamination of the environment or intravenous medication vials. fastidious attention to aseptic technique and infection control precautions are essential to prevent hcv transmission. | 2009 | 19642900 |
| incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes. | orthotopic liver transplantation (olt) is the only effective treatment for end-stage liver disease. although most patients do well and are discharged promptly, some require prolonged length of stay (plos). the prevalence of plos, associated factors, and their impact on survival are not well defined. we reviewed our adult olt database for patients who survived > 30 days. plos was defined as hospitalization > 30 days following olt. of 521 olt recipients, 68 (13%) had plos with a median duration of ... | 2009 | 19243008 |
| hepatitis c treatment eligibility and outcomes among patients with psychiatric illness. | this study characterized the utilization and outcomes of hepatitis c virus (hcv) treatment among patients with psychiatric illness. | 2006 | 16603757 |
| a comparison of the spectrum of chronic hepatitis c virus between caucasians and african americans. | differences in hepatitis c virus (hcv)-related liver disease between caucasians and african americans remain controversial. | 2004 | 15181614 |